Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Monika Rygielska"'
Autor:
Katarzyna Pawińska-Wąsikowska, Małgorzata Czogała, Karolina Bukowska-Strakova, Marta Surman, Monika Rygielska, Teofila Książek, Beata Sadowska, Agnieszka Pac, Jolanta Skalska-Sadowska, Magdalena Samborska, Jacek Wachowiak, Małgorzata Ciebiera, Radosław Chaber, Renata Tomaszewska, Tomasz Szczepański, Karolina Zielezińska, Tomasz Urasiński, Anna Rodziewicz-Konarska, Krzysztof Kałwak, Marta Kozłowska, Ninela Irga-Jaworska, Barbara Sikorska-Fic, Bartosz Chyżyński, Paweł Łaguna, Katarzyna Muszyńska-Rosłan, Maryna Krawczuk-Rybak, Paulina Deleszkiewicz, Katarzyna Drabko, Katarzyna Bobeff, Wojciech Młynarski, Agnieszka Chodała-Grzywacz, Grażyna Karolczyk, Katarzyna Mycko, Wanda Badowska, Natalia Bartoszewicz, Jan Styczyński, Katarzyna Machnik, Weronika Stolpa, Agnieszka Mizia-Malarz, Walentyna Balwierz, Szymon Skoczeń
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
BackgroundA personalised approach to the treatment of acute myeloid leukemia (AML) in children and adolescents, as well as the development of supportive therapies, has significantly improved survival. Despite this, some patients still die before star
Externí odkaz:
https://doaj.org/article/5ff981bb50e347aeb53dd036a007a151
Autor:
Katarzyna Pawinska-Wasikowska, Malgorzata Czogala, Szymon Skoczen, Marta Surman, Monika Rygielska, Teofila Ksiazek, Agnieszka Pac, Aleksandra Wieczorek, Jolanta Skalska-Sadowska, Magdalena Samborska, Jacek Wachowiak, Radoslaw Chaber, Renata Tomaszewska, Tomasz Szczepanski, Karolina Zielezinska, Tomasz Urasinski, Malgorzata Moj-Hackemer, Krzysztof Kalwak, Marta Kozlowska, Ninela Irga-Jaworska, Walentyna Balwierz, Karolina Bukowska-Strakova
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundGemtuzumab ozogamicin (GO), one of the first targeted drugs used in oncology, consists of an anti-cluster of differentiation 33 (CD33) monoclonal antibody bound to a derivative of cytotoxic calicheamicin. After the drug withdrawn in 2010 du
Externí odkaz:
https://doaj.org/article/4f6992bae96b4263b3d4ca86cbcc89e8
Autor:
Katarzyna Pawińska-Wa̧sikowska, Magdalena Cwiklinska, Elzbieta Wyrobek, Walentyna Balwierz, Karolina Bukowska-Strakova, Agnieszka Dluzniewska, Jolanta Gozdzik, Grazyna Drabik, Monika Rygielska, Konrad Stepien, Szymon Skoczen
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
The association between acute lymphoblastic leukemia (ALL), non-Langerhans cell histiocytosis (non-LCH), and hemophagocytic lymphohistiocytosis (HLH), to the best of our knowledge, has not been published to date. Juvenile xanthogranuloma (JXG), as a
Externí odkaz:
https://doaj.org/article/853d2ee3984e4c6fb29b8e7bcca39113
Autor:
Katarzyna Pawinska-Wasikowska, Karolina Bukowska-Strakova, Marta Surman, Monika Rygielska, Beata Sadowska, Teofila Ksiazek, Tomasz Klekawka, Aleksandra Wieczorek, Szymon Skoczen, Walentyna Balwierz
Publikováno v:
Cancers; Volume 14; Issue 21; Pages: 5359
Measurable residual disease (MRD) is a well-known tool for the evaluation of the early response to treatment in patients with acute lymphoblastic leukemia (ALL). In respect to predicting the relapse the most informative cut-off and time point of MRD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f3071c08e5ed03e5c132052cc258c79
Autor:
Elżbieta Wyrobek, Magdalena Ćwiklińska, Jolanta Gozdzik, Karolina Bukowska-Strakova, Szymon Skoczeń, Agnieszka Dluzniewska, Katarzyna Pawińska-Wa Sikowska, Monika Rygielska, Konrad Stepien, Walentyna Balwierz, Grazyna Drabik
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
The association between acute lymphoblastic leukemia (ALL), non-Langerhans cell histiocytosis (non-LCH), and hemophagocytic lymphohistiocytosis (HLH), to the best of our knowledge, has not been published to date. Juvenile xanthogranuloma (JXG), as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec10be06641186a60d77874f5c8ddbf3
http://europepmc.org/articles/PMC7350519
http://europepmc.org/articles/PMC7350519
Autor:
Magdalena, Cwiklińska, Małgorzata, Czogała, Walentyna, Balwierz, Małgorzata, Hnatko-Kołacz, Angelina, Moryl-Bujakowska, Iwona, Malinowska, Małgorzata, Sładek, Maria, Wieczorek, Krzysztof, Fyderek, Michał, Matysiak, Monika, Rygielska, Iwona, Sierhej
Publikováno v:
Przeglad lekarski. 67(6)
Hemophagocytic syndrome (HS) is a life-threatening condition of hyperinflammation. Main symptoms are: prolonged fever, cytopenia, hepatosplenomegaly, hemophagocytosis, hyperferritinemia, hypertriglyceridemia and hypofibrinogenemia. Primary genetic fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::309baee5d8792637e4cdfe095d537659
https://pubmed.ncbi.nlm.nih.gov/21344776
https://pubmed.ncbi.nlm.nih.gov/21344776